Health
AstraZeneca denies vaccine trial subject had nerve ailment – The Peninsula Qatar
Trials of the Oxford-Astra vaccine resumed in the U.K. over the weekend, after a pause to investigate the adverse event, while researchers in South Africa also restarted tests.
AstraZeneca Plc, the drugmaker working with the University of Oxford on a Covid-19 vaccine, contradicted a report that a volunteer in U.K. tests of the shot developed a rare nerve disease that might have signaled severe safety problems.
AstraZeneca was responding Thursday to a CNN report citing documents indicating that the diagnosis of the participant was confirmed as transverse myelitis. The diagnosis was “based on preliminary findings,” and is inaccurate, the Cambridge, England-based drugmak…
-
Noosa News14 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News20 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Business19 hours agoAre BHP shares are buy after its results?
-
General23 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply